You are here

briakinumab

Psoriasis Drug Setback Highlights Abbott Pipeline Weaknesses

Seeking Alpha

Tue, 01/18/11 - 07:56 am

Abbott Laboratories

Abbott Laboratories Withdrew U.S. BLA, MAA for Briakinumab

Bloomberg

Fri, 01/14/11 - 10:01 am

Abbott Laboratories

monoclonal antibodies